Back to User profile » Dr David L Wirta
Papers published by Dr David L Wirta:
Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution
Gonzalez VH, Wirta DL, Uram M, Schupp A, Widmann M, Novack GD
Clinical Ophthalmology 2023, 17:1357-1365
Published Date: 10 May 2023
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease
Holland EJ, Loh J, Bloomenstein M, Thompson V, Wirta D, Dhamdhere K
Clinical Ophthalmology 2022, 16:2861-2871
Published Date: 30 August 2022
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
Wirta DL, Korenfeld MS, Foster S, Smyth-Medina R, Bacharach J, Kannarr SR, Jaros MJ, Slonim CB
Clinical Ophthalmology 2021, 15:4035-4048
Published Date: 8 October 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results
Bacharach J, Wirta DL, Smyth-Medina R, Korenfeld MS, Kannarr SR, Foster S, Jaros MJ, Slonim CB
Clinical Ophthalmology 2021, 15:2743-2751
Published Date: 25 June 2021
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
Karpecki P, Wirta D, Osmanovic S, Dhamdhere K
Clinical Ophthalmology 2020, 14:4551-4559
Published Date: 30 December 2020